|
MPHOSPH8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31621405283522E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.57039977980389E-10 |
| Normal-vs-Stage2 |
8.5717999998014E-07 |
| Normal-vs-Stage3 |
1.56839985443469E-10 |
| Normal-vs-Stage4 |
2.23810003863179E-09 |
| Stage1-vs-Stage2 |
5.817400E-01 |
| Stage1-vs-Stage3 |
1.418830E-01 |
| Stage1-vs-Stage4 |
1.500410E-01 |
| Stage2-vs-Stage3 |
6.352400E-01 |
| Stage2-vs-Stage4 |
6.095200E-01 |
| Stage3-vs-Stage4 |
9.360800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.93369797741161E-12 |
| Normal-vs-AfricanAmerican |
1.696120E-02 |
| Normal-vs-Asian |
1.49069999999529E-06 |
| Caucasian-vs-AfricanAmerican |
4.518300E-02 |
| Caucasian-vs-Asian |
8.417600E-01 |
| AfricanAmerican-vs-Asian |
1.328400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-14 |
| Normal-vs-Female |
4.62859972572005E-10 |
| Male-vs-Female |
1.233640E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.62009996926582E-09 |
| Normal-vs-Age(41-60Yrs) |
5.7409998976965E-10 |
| Normal-vs-Age(61-80Yrs) |
4.16130019331717E-10 |
| Normal-vs-Age(81-100Yrs) |
7.97040000000138E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.801600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.625560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.146980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.483800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.715170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.057200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.209500E-02 |
| Classical-VS-Follicular |
1.633650E-02 |
| Classical-VS-Other |
4.272800E-01 |
| Classical-VS-Normal |
1.36199995726116E-09 |
| Tall-VS-Follicular |
5.083000E-01 |
| Tall-VS-Other |
6.959200E-01 |
| Tall-VS-Normal |
1.93229998668443E-09 |
| Follicular-VS-Other |
9.782000E-01 |
| Follicular-VS-Normal |
2.48249998335837E-09 |
| Other-VS-Normal |
5.520300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10279588081153E-11 |
| Normal-vs-N1 |
2.31740000522507E-08 |
| N0-vs-N1 |
5.647600E-01 |
|
|
